IRIX News and Press, IRIDEX Corporation From 11/01/23

2023-11-01 08:51:55 ET Losers: WeWork ( WE ) -40% . Paycom Software ( PAYC ) -38% after Q3 earning release . IRIDEX Corp. ( IRIX ) -15% . Silicon Laboratories ( SLAB ) -26% after Q3 earning release . Extreme Networks ( EXTR )...

Shares of IRIDEX Corporation (NASDAQ: IRIX) traded at a new 52-week high today and are currently trading at $3.16. So far today, approximately 107.22k shares have been exchanged, as compared to an average 30-day volume of 109.11k shares. IRIDEX Corporation, an ophthalmic medical technology co...

MOUNTAIN VIEW, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the third quarter of...

2023-10-04 05:04:03 ET Summary IRIDEX Corporation is a leading provider of laser-based retinal treatments and is respected in the ophthalmic industry. IRIX stock has experienced a significant decline in value, but the primary reason for this (dilution concerns) is misguided. T...

2023-08-29 16:36:34 ET More on IRIDEX IRIDEX Corporation ( IRIX ) Q2 2023 Earnings Call Transcript IRIDEX GAAP EPS of -$0.17 misses by $0.06, revenue of $12.9M misses by $1.33M IRIDEX GAAP EPS of -$0.07 beats by $0.04, revenue of $15.2M beats by $0.04M Ir...

MOUNTAIN VIEW, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) announced today that its Board of Directors is undertaking, in consultation with its financial and legal advisors, a review and evaluation of strategic alternatives that may be available to the Company to u...

2023-08-10 20:33:06 ET IRIDEX Corporation (IRIX) Q2 2023 Earnings Conference Call August 10, 2023, 17:00 ET Company Participants Philip Taylor - Gilmartin Group David Bruce - President, CEO & Director Fuad Ahmad - Interim Chief Financial Officer Confere...

2023-08-10 16:09:59 ET IRIDEX press release ( NASDAQ: IRIX ): Q2 GAAP EPS of -$0.17 misses by $0.06 . Revenue of $12.9M (-6.5% Y/Y) misses by $1.33M . With lower than expected probe unit sales growth and capital equipment softness in the first half of the year,...

MOUNTAIN VIEW, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today reported financial results for the second quarter ended July 1, 2023. Seco...

MOUNTAIN VIEW, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the second quarter o...